Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.

The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just announced the publication of its pivotal paper in The ...

Careful consideration of individual patient factors and thorough consultations are key for pharmacists to maximize their impact on cancer care access and adherence, according to Ryan Haumschild, ...